HomeInsightsStock Comparison

Astrazeneca Pharma India Ltd vs Iol Chemicals Pharmaceuticals Ltd Stock Comparison

Astrazeneca Pharma India Ltd vs Iol Chemicals Pharmaceuticals Ltd Stock Comparison

Last Updated on: Jun 07, 2025

Key Highlights

  • The Latest Trading Price of Astrazeneca Pharma India Ltd is ₹ 9791 as of 06 Jun 15:30.
  • The P/E Ratio of Astrazeneca Pharma India Ltd is 0 as of March 2022 .The P/E Ratio of IOL Chemicals & Pharmaceuticals Ltd is 12.4 as of March 2022.
  • The Market Cap of Astrazeneca Pharma India Ltd is ₹ 0 crore as of March 2022 .The Market Cap of IOL Chemicals & Pharmaceuticals Ltd is ₹ 2077 crore as of March 2022.
  • The revenue of Astrazeneca Pharma India Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of IOL Chemicals & Pharmaceuticals Ltd for the Mar '25 is ₹ 532.3 crore as compare to the Dec '24 revenue of ₹ 527.37 crore. This represent the growth of 0.93%.
  • The ebitda of Astrazeneca Pharma India Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of IOL Chemicals & Pharmaceuticals Ltd for the Mar '25 is ₹ 67.28 crore as compare to the Dec '24 ebitda of ₹ 50.94 crore. This represent the growth of 32.08%.
  • The net profit of Astrazeneca Pharma India Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of IOL Chemicals & Pharmaceuticals Ltd changed from ₹ 45.86 crore to ₹ 31.42 crore over 8 quarters. This represents a CAGR of -17.23% .
  • The Dividend Payout of Astrazeneca Pharma India Ltd changed from 3.46 % on March 2020 to 37.15 % on March 2024 . This represents a CAGR of 60.76% over 5 yearsThe Dividend Payout of IOL Chemicals & Pharmaceuticals Ltd changed from 4.77 % on March 2020 to 21.68 % on March 2024 . This represents a CAGR of 35.37% over 5 years.

Share Price

* All values are in Rupees

PE

Market Cap

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Astrazeneca Pharma India Ltd

  • AstraZeneca Pharma India Limited (APIL) was incorporated on July 11, 1979.
  • The Company is engaged in the business of manufacture, distribution and marketing of pharmaceutical products and co-ordinates clinical trial services with an overseas group company.
  • The major therapy areas where the company operates are Onocology, Alimentary & Metabolism, Cardio Vascular, Renal, Diabetes, Respiratory and Oncology. AstraZeneca Pharma India, formerly known as Astra-IDL (AIL), was an erstwhile joint venture of Astra Zeneca, UK and Hinduja controlled IDL. Astra Pharmaceuticals AB, Sweden acquired all of the 1287500 equity shares in the Company of IDL, representing 25.75% of the Company's issued and paid up equity share capital.
  • Consequently, the Company became a subsidiary of Astra, which is a direct wholly owned subsidiary of Astra AB, Sweden (now known as AstraZeneca Pharmaceuticals AB Sweden) and an indirect wholly owned subsidiary of AstraZeneca Plc, the Group parent Company.

About IOL Chemicals & Pharmaceuticals Ltd

  • IOL Chemicals and Pharmaceuticals Limited, incorporated in September, 1986 is a renowned company in the Active Pharmaceutical Ingredient (API) and specialty chemicals sectors.
  • With substantive manufacturing capacities, the Company benefits from economies of scale and cost supremacy.
  • Its extensive expertise in both API and specialty chemicals strengthens its business model and opens doors to diversified growth opportunities. Within the API segment, IOL develops and supplies a wide range of essential products utilized by pharmaceutical companies worldwide for the production of key medicines.
  • It serves as a global supplier of various APIs, including Ibuprofen, Metformin, Clopidogrel, Lamotrigine, Pantoprazole, and Fenofibrate, alongside other APIs, and maintains a significant presence in all major therapeutic categories.

Astrazeneca Pharma India Ltd News Hub

News

Astrazeneca Pharma India Ltd Spurts 7.28%

Astrazeneca Pharma India Ltd gained 7.28% today to trade at Rs 8545.4. The BSE Healthcare ...

Read more

02 Jun 2025 09:30

News

AstraZeneca Pharma soars after Q4 PAT jumps 48% YoY

Profit before tax (PBT) stood at Rs 78.47 crore in Q4 FY25, up 44.35% year-on-year, and up...

Read more

02 Jun 2025 10:10

News

Volumes soar at Astrazeneca Pharma India Ltd counter

Max Healthcare Institute Ltd, Godrej Consumer Products Ltd, Mphasis Ltd, Indraprastha Gas ...

Read more

02 Jun 2025 11:00

News

Astrazeneca Pharma India Ltd leads gainers in 'A' group

Sun Pharma Advanced Research Company Ltd, Bank of Maharashtra, Reliance Power Ltd and Genu...

Read more

02 Jun 2025 12:00

News

Volumes spurt at Astrazeneca Pharma India Ltd counter

Niva Bupa Health Insurance Company Ltd, Indian Overseas Bank, Sterling & Wilson Renewable ...

Read more

02 Jun 2025 14:30

News

AstraZeneca Pharma receives marketing approval for Benralizumab in India

AstraZeneca Pharma India has received permission from the Central Drugs Standard Control O...

Read more

30 May 2025 09:16

IOL Chemicals & Pharmaceuticals Ltd News Hub

News

IOL Chemicals & Pharmaceuticals to conduct AGM

IOL Chemicals & Pharmaceuticals announced that the 38th Annual General Meeting(AGM) of the...

Read more

17 May 2025 16:26

News

IOL Chemicals & Pharmaceuticals to table results

IOL Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Compa...

Read more

07 May 2025 11:08

News

IOL Chemicals gets approval from CDE to export Ibuprofen to China

This approval authorizes the company to export Ibuprofen to the Chinese markets. Ibuprofen...

Read more

29 Apr 2025 07:49

News

IOL Chemicals jumps after receiving CEP for Quetiapine Fumarate

The said certification will enable the company to export Quetiapine Fumarate to European a...

Read more

06 Mar 2025 10:27

News

Board of IOL Chemicals & Pharmaceuticals recommends interim dividend

IOL Chemicals & Pharmaceuticals announced that the Board of Directors of the Company at it...

Read more

13 Feb 2025 09:31

News

IOL Chemicals & Pharmaceuticals to declare Quarterly Results

IOL Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Compa...

Read more

05 Feb 2025 11:25

SWOT Analysis Of IOL Chemicals & Pharmaceuticals Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for IOL Chemicals & Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Astrazeneca Pharma India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Astrazeneca Pharma India Ltd and IOL Chemicals & Pharmaceuticals Ltd

Which company has a larger market capitalization, Astrazeneca Pharma India Ltd or IOL Chemicals & Pharmaceuticals Ltd?

Market cap of Astrazeneca Pharma India Ltd is 24,479 Cr while Market cap of IOL Chemicals & Pharmaceuticals Ltd is 2,600 Cr

What are the key factors driving the stock performance of Astrazeneca Pharma India Ltd and IOL Chemicals & Pharmaceuticals Ltd?

The stock performance of Astrazeneca Pharma India Ltd and IOL Chemicals & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Astrazeneca Pharma India Ltd and IOL Chemicals & Pharmaceuticals Ltd?

As of June 7, 2025, the Astrazeneca Pharma India Ltd stock price is INR ₹9791.9. On the other hand, IOL Chemicals & Pharmaceuticals Ltd stock price is INR ₹88.61.

How do dividend payouts of Astrazeneca Pharma India Ltd and IOL Chemicals & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Astrazeneca Pharma India Ltd and IOL Chemicals & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions